Pfizer’s RSV vaccine shows potential to protect high-risk adults ages 18-59, widening possible use

Respiratory syncytial virus – viral vaccine under research Hailshadow | Istock | Getty Images A vaccine…

Pfizer is betting big on cancer drugs to turn business around after Covid decline – here’s what to know

Nurphoto | Nurphoto | Getty Images Pfizer is ready to move on from Covid.  Now, the…

Pfizer RSV vaccine maintains protection in older adults over two seasons in trial

Respiratory syncytial virus vial. Manjurul | Istock | Getty Images Pfizer‘s vaccine against respiratory syncytial virus…

Viking Therapeutics stock jumps 80% after positive weight loss drug trial results

Cr | Istock | Getty Images Shares of Viking Therapeutics soared more than 80% in premarket…

Federal judge tosses lobbying group’s lawsuit challenging Medicare drug price negotiations

Activists protest the price of prescription drug costs in front of the U.S. Department of Health…

Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that

Injection pens of Novo Nordisk’s weight-loss drug Wegovy are shown in this photo illustration in Oslo,…

Bristol Myers Squibb results top estimates as new drugs post strong sales growth 

Bristol Myers Squibb reported quarterly earnings and revenue that topped expectations on Friday as its portfolio…

GSK posts blowout RSV vaccine sales, raises outlook as shots give big pharma a boost

Company logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility, Britain October 26, 2020. …

Pfizer beats earnings estimates as declining Covid business loses less revenue than expected

Pfizer on Tuesday posted a surprise adjusted fourth-quarter profit, as the company’s declining Covid business performed…

The weight loss drug market may soon get more crowded. Here are the companies trying to enter the booming space

Still life of Wegovy an injectable prescription weight loss medicine that has helped people with obesity.…